Key facts
- This page summarizes Michael A. Martino's Form 4 filing for Ampio Pharmaceuticals, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 May 2023, 13:30.
Michael A. Martino - 24 May 2023 Form 4 Insider Report for Ampio Pharmaceuticals, Inc.
- Reporting relationship
- CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 24 May 2023
- Net transaction value
- +$22,121
- SEC form
- 4
- Accepted by SEC
- 26 May 2023, 13:30:43 UTC
- Prior SEC filing
- 03 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- Suzette McNally, Attorney-in-Fact for Michael A. Martino
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael A. Martino filed Form 4 for Ampio Pharmaceuticals, Inc. on 26 May 2023.
Change
- Previous filing in this sequence was filed on 03 Jan 2022.
- Current net transaction value: +$22,121.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMPE
transaction
Common Stock
Purchase
- Transaction value
- $22,121
- Shares
- +76,890
- Change %
- Price
- $0.2877
- Shares after
- 76,890
- Date
- 24 May 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.